Article
Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant.
Journal of virology - 1 Aug 2007
Opi Sandrine, Kao Sandra, Goila-Gaur Ritu, Khan Mohammad A, Miyagi Eri, Takeuchi Hiroaki, Strebel Klaus
Abstract excerpt
Human immunodeficiency virus type 1 (HIV-1) Vif counteracts the antiviral activity of the human cytidine deaminase APOBEC3G (APO3G) by inhibiting its incorporation into virions. This has been attributed to the Vif-induced degradation of APO3G by cytoplasmic proteasomes. We recently demonstrated that although APO3G has a natural tendency to form RNA-dependent homo-multimers, multimerization was not essential for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
